Differential patterns of histone acetylation in inflammatory bowel diseases

Journal of Inflammation

Volumn 8, Issue , 2011, Pages

  Tsaprouni, Loukia G ^a   Ito, Kazuhiro ^a   Powell, Jonathan J ^c   Adcock, Ian M ^a   Punchard, Neville ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; HISTONE H3; HISTONE H4; LYSINE; TRINITROBENZENESULFONIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DRUG TARGETING; ENTERITIS; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTESTINE MUCOSA; MALE; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; TISSUE CHARACTERIZATION; TISSUE SPECIFICITY;

ANIMALIA; RATTUS;

EID: 79251550434     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-8-1     Document Type: Article

References (63)

1. Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369(9573):1627-1640. (Pubitemid 46722636)
2. D'Haens G, Daperno M: Advances in biologic therapy for ulcerative colitis and Crohn's disease. Curr Gastroenterol 2006, 8(6):506-512. (Pubitemid 46017163)
3. Travis S: Advances in therapeutic approaches to ulcerative colitis and Crohn's disease. Curr Gastroenterol 2005, 7(6):475-484.
4. Neurath M, Fuss I, Strober W: TNBS-colitis. Int Rev Immunol 2000, 19:51-62. (Pubitemid 30146942)
5. Fujno K, Takami Y, dela Fuente SG, Ludwig KA, Mantyh CR: Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis. J of Gastrointestinal Surg 2004, 8(7):842-848. (Pubitemid 41115737)
6. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyoto H, McGhee JR: Hapten-induced colitis is associated with colonic patch hypertrophy and T Helper cell-2-type responses. J Exp Med 1999, 189:1169-1179. (Pubitemid 29198256)
7. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X: Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflammatory Bowel Diseases 2008, 15(3):341-352.
8. Zaph C, Troy AE, Taylor BC, Berman-Booty LD, Guild KJ, Du Y, Yost EA, Gruber AD, May MJ, Greten FR, Eckmann L, Karin M, Artis D: Epithelial-cell- intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 2007, 446:552-556. (Pubitemid 46514719)
9. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, Gumucio D, Neurath MF, Pasparakis M: Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
10. Murano M, Maemura K, Hirata I, Toshina K, Nishikawa T, Hamamoto N, Sasaki S, Saitoh O, Katsu K: Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol 2000, 120:51-58.
11. Herfarth H, Brand K, Rath HC, Rogler G, Scholmerich J, Falk W: Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol 2000, 120:59-65. (Pubitemid 30176900)
12. Fitzpatrick LR, Wang J, Le T: In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats. Dig Dis Sci 2000, 45:2327-2336.
13. Rahman I, Marwick J, Kirkham P: Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression. Biochem Pharmacol 2004, 68(6):1255-1267.
14. Place RF, Noonan EJ, Giardina C: HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IêBá. Biochem Pharmacol 2005, 70:394-406. (Pubitemid 40905111)
15. Siavoshian S, Segain JP, Kornprobst M, Bonnet C, Cherbut C, Galmiche JP, Blottiere HM: Butyrate and trichostatin A effects on the proliferation/ differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 2000, 46:507-514. (Pubitemid 30305815)
16. Glauben R, Batra A, Fedke I, Zeitz M, Lehr HA, Leoni F, Mascagni P, Fantuzzi G, Dinarello CA, Siegmund B: Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 2006, 176:5015-5022.
17. Roy CC, Kien CL, Bouthillier L, Levy E: Short-chain fatty acids: ready for prime time? Nutr Clin Pract 2006, 21(4):351-366.
18. Park JS, Lee EJ, Lee JC, Kim WK, Kim HS: Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signalling pathways. Int Immunopharmacol 2007, 7(1):70-77.
19. Xu WS, Parmigiani RB, Marks PA: Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007, 26(37):5541-5552. (Pubitemid 47255934)
20. Bhavsar P, Ahmad T, Adcock IM: The role of histone deacetylases in asthma and allergic diseases. J Allergy Clin Immunol 2008, 121(3):580-584.
21. Matthews JG, Ito K, Barnes PJ, Adcock IM: Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 2004, 113:1100-1108. (Pubitemid 38857992)
22. + T cells. Blood 2007, 110(5):1570-1577.
23. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Pérez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Gen 2005, 37(4):391-400.
24. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL: Hapten-induced models of chronic inflammation and ulceration in the rat colon. Gastroenterol 1989, 96:795-803. (Pubitemid 19057602)
25. Vowinkel T, Kalogeris TJ, Mori M, Krieglstein CF, Granger DN: Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci 2004, 49(4):556-564. (Pubitemid 38992541)
26. Ellis RD, Goodlad JR, Limb GA, Powell JJ, Thompson RP, Punchard NA: Activation of nuclear factor kappa B in Crohn's disease. Inflamm Res 1998, 47:440-445. (Pubitemid 28532654)
27. Ito K, Barnes PJ, Adcock IM: Histone acetylation and histone deacetylation. Methods in Molecular Medicine. Asthma: Mechanisms and Protocols 2000, 44:309-319.
28. Ito K, Barnes PJ, Adcock IM: Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000, 20(18):6891-6903.
29. Ito K, Caramori G, Lim S, Oats T, Chung KF, Barnes PJ, Adcock IM: Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med 2002, 166(3):392-396. (Pubitemid 34864433)
30. Neurath MF, Finotto S, Fuss I, Boirivant M, Galle PR, Strober W: Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol 2001, 22:21-26. (Pubitemid 32675276)
31. Schreiber S: Inflammatory bowel disease: Immunologic concepts. Hepato- Gastroenterol 2000, 47:15-28.
32. Adcock IM, Cosio B, Tsaprouni L, Barnes PJ, Ito K: Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid Redox Signal 2005, 7(1-2):144-152. (Pubitemid 40187932)
33. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM: Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappa B suppression. J Exp Med 2006, 203(1):7-13. (Pubitemid 43139638)
34. Ashburner BP, Westerheide SD, Baldwin AS Jr: The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Molecular and Cellular Biology 2001, 21:7065-7077. (Pubitemid 32916079)
35. Ben-Neriah Y, Schmidt-Supprian M: Epithelial NF-kappaB maintains host gut microflora homeostasis. Nat Immunol 2007, 8(5):479-481. (Pubitemid 46605915)
36. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ: Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27(2):104-119. (Pubitemid 350256609)
37. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, Eckmann L, Karin M: Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005, 307(5710):734-738. (Pubitemid 40194645)
38. Vettese-Dadey M, Grant PA, Hebbes TH, Crane-Robinson C, Allis CD, Workman JL: Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J 1996, 15(10):2508-2518. (Pubitemid 26151190)
39. Nie M, Knox AJ, Pang L: Beta-2 Adrenoreceptor agonists, like glucocorticoids repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 2005, 175:478-486. (Pubitemid 40884352)
40. Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, Collins HM, Soria D, Garibaldi JM, Paish CE, Ammar AA, Grainge MJ, Ball GR, Abdelghany MK, Martinez-Pomares L, Heery DM, Ellis IO: Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome. Cancer Res 2009, 69(9):3802-3809.
41. Arts J, Lansink M, Grimbergen J, Toet KH, Kooistra T: Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J 1995, 310:171-176.
42. Song M, Xia B, Li J: Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgrad Med J 2006, 82(964):130-135. (Pubitemid 43266142)
43. Chen L, Fischle W, Verdin E, Greene WC: Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001, 293:1653-1657. (Pubitemid 32807844)
44. Smoak KA, Cidlowski JA: Mechanisms of glucocorticoid receptor signalling during inflammation. Mechs Age Dev 2004, 125:697-706. (Pubitemid 39482400)
45. Hoffmann A, Natoli G, Ghosh S: Transcriptional regulation via the NF-κB signalling module. Oncogene 2006, 25:6706-6716. (Pubitemid 44657847)
46. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM: Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001, 15:1110-1112.
47. Malo MS, Biswas S, Abedrapo MA, Yeh L, Chen A, Hodin RA: The proinflammatory cytokines, IL-1β and TNF-α, inhibit intestinal alkaline phosphatase gene expression. DNA and Cell Biology 2006, 25(12):684-695. (Pubitemid 46052614)
48. Wang L, Kametani Y, Katano I, Habu S: T-cell specific enhancement of histone H3 acetylation in 5′ flanking region of the IL-2 gene. Biochem and Bipophys Commun 2005, 331(2):589-594. (Pubitemid 40613024)
49. Letting DL, Rakowski C, Weiss MJ, Blobel GA: Formation of a Tissue- Specific Histone Acetylation Pattern by the Hematopoietic Transcription Factor GATA-1. Mol and Cell Biol 2003, 23(4):1334-1340. (Pubitemid 36177041)
50. Wako T, Houben A, Furushima-Shimogawara R, Belyaev ND, Fukui K: Centromere-specific acetylation of histone H4 in barley detected through three-dimensional microscopy. Plant Mol Biol 2003, 51(4):533-541. (Pubitemid 36325929)
51. Quary S, Bizat N, Altairac S, Menetrat H, Mittoux V, Conde F, Hantraye P, Brouillet E: Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications of neuroprotection studies. Neuroscience 2000, 97:521-530. (Pubitemid 30320758)
52. Jurado F, Bellon JM, Golitsin A, Gimero MJ, Pascual G, Bujan J: Role of macrophages in myocardial apoptosis following cardiac transplant. Influence of immunosuppressive treatment. Histology and Histopathology 1999, 14:1033-1043.
53. Ejsing-Duun M, Josephsen J, Aasted B, Buschard K, Hansen AK: Dietary Gluten Reduces the Number of Intestinal Regulatory T Cells in Mice. Scandinavian Journal of Immunol 2008, 67:553-559. (Pubitemid 351677413)
54. Shahbazian MD, Grunstein M: Functions of site-specific histone acetylation and deacetylation. Annual Review of Biochem 2007, 76:75-100.
55. Verreault A, Kaufman PD, Kobayashi R, Stillman B: Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell 1996, 87:95-104. (Pubitemid 26337394)
56. Liou GG, Tanny JC, Kruger RG, Walz T, Moazed D: Asssembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation. Cell 2005, 121:515-527. (Pubitemid 40720006)
57. Hartman HB, Yu J, Alenghat T, Ishizuka T, Lazar MA: The histone binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep 2005, 6:445-451. (Pubitemid 40767078)
58. Wang A, Kurdistani SK, Grunstein M: Requirement of Hos2 histone deacetylase for gene activity in yeast. Science 2002, 298(5597):1412-1414. (Pubitemid 35346139)
59. Adcock IM, Caramori G: Cross talk between pro-inflammatory transcription factors and glucocorticoids. Immunol and Cell Biol 2001, 79:376-384. (Pubitemid 32744283)
60. Dokmanovic M, Clarke C, Marks PA: Histone deacetylase inhibitors: Overview and perspectives. Mol Cancer Res 2007, 5(10):981-989. (Pubitemid 350080267)
61. Tao R, de Zoeten EF, Özkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, Wells AD, Hancock WW: Deacetylase inhibition promotes the generation and function of regulatory T cells. Nature Medicine 2007, 13(11):1299-1307. (Pubitemid 350073591)
62. Tsuji NM, Mizumachi K, Kurisaki J: Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 2001, 103(4):458-464. (Pubitemid 32744392)
63. Ma X, Ezzeldin HH, Diasio RB: Histone deacetylase inhibitors: Current status and overview of recent clinical trials. Drugs 2009, 69(14):1911-1934.